John G Ullman & Associates Inc Eli Lilly & CO Transaction History

John G Ullman & Associates Inc

$630 Million
Q1 2024

A detailed history of John G Ullman & Associates Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, John G Ullman & Associates Inc holds 3,558 shares of LLY stock, worth $3.23 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

3,558

Previous 3,998 11.01%

Holding current value

$3.23 Million

Previous $2.33 Million 18.76%

% of portfolio

0.44%

Previous 0.38%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$592.2 - $792.28 $260,568 - $348,603	-440 Reduced 11.01%	3,558 $2.77 Million
Q3 2023 Nov 01, 2023	BUY	$434.7 - $599.3 $13,041 - $17,979	30 Added 0.76%	3,998 $2.15 Million
Q1 2023 May 05, 2023	SELL	$310.63 - $364.82 $20,501 - $24,078	-66 Reduced 1.64%	3,968 $1.36 Million
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $5,144 - $5,994	16 Added 0.4%	4,034 $1.48 Million
Q3 2022 Oct 19, 2022	SELL	$296.48 - $337.87 $29,648 - $33,787	-100 Reduced 2.43%	4,018 $1.3 Million

Q1 2022 Apr 29, 2022	BUY	$234.69 - $291.66 $10,795 - $13,416	46 Added 1.13%	4,118 $1.18 Million
Q4 2021 Jan 26, 2022	BUY	$224.85 - $279.04 $3,822 - $4,743	17 Added 0.42%	4,072 $1.13 Million
Q3 2021 Nov 02, 2021	SELL	$221.6 - $272.71 $70,025 - $86,176	-316 Reduced 7.23%	4,055 $937,000
Q2 2021 Jul 23, 2021	BUY	$180.55 - $233.54 $38,998 - $50,444	216 Added 5.2%	4,371 $1 Million
Q4 2020 Feb 05, 2021	BUY	$130.46 - $172.63 $52,184 - $69,052	400 Added 10.65%	4,155 $702,000
Q2 2020 Jul 29, 2020	SELL	$136.42 - $164.18 $33,422 - $40,224	-245 Reduced 6.13%	3,755 $616,000
Q1 2020 Apr 14, 2020	SELL	$119.05 - $147.35 $17,857 - $22,102	-150 Reduced 3.61%	4,000 $555,000
Q4 2019 Jan 29, 2020	BUY	$106.92 - $132.43 $5,346 - $6,621	50 Added 1.22%	4,150 $545,000
Q3 2019 Oct 21, 2019	BUY	$106.79 - $116.16 $42,716 - $46,464	400 Added 10.81%	4,100 $458,000
Q1 2019 Apr 30, 2019	SELL	$111.31 - $131.02 $5,676 - $6,682	-51 Reduced 1.36%	3,700 $480,000
Q2 2018 Jul 23, 2018	BUY	$75.7 - $86.88 $75,700 - $86,880	1,000 Added 36.35%	3,751 $320,000
Q1 2018 Apr 19, 2018	SELL	$74.21 - $87.6 $28,941 - $34,164	-390 Reduced 12.42%	2,751 $213,000
Q4 2017 Jan 31, 2018	BUY	$81.94 - $87.89 $257,373 - $276,062	3,141	3,141 $265,000

Others Institutions Holding LLY

# of Institutions

3,721

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $862B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of John G Ullman & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on John G Ullman & Associates Inc with notifications on news.

Account

John G Ullman & Associates Inc Eli Lilly & CO Transaction History